Lonza News Nov 21, 2025 Gene Therapy Cell Culture Media Market By Top Companies-Lonza - openPR.com #Therapy Cell #Cell Culture
Lonza News Oct 17, 2025 Lonza expands its GMP solutions for cell and gene therapy - SelectScience #GMP solutions #Lonza expands
Lonza News Oct 6, 2025 Lonza Expands Cell and Gene Therapy Portfolio - Contract Pharma #Expands Cell #Gene Therapy
Lonza News Sep 26, 2025 Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC Development - GEN - Genetic Engineering and Biotechnology News #Genetic Engineering #Synaffix Collaborates
Lonza News Sep 23, 2025 Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics - GEN - Genetic Engineering and Biotechnology News #Genetic Engineering #Scale Manufacturing
Lonza News Sep 15, 2025 Top 10 Contract Development and Manufacturing Organizations 2025 - GEN - Genetic Engineering and Biotechnology News #Contract Development #Manufacturing Organizations
Lonza News Sep 12, 2025 Lonza’s UC-II Collagen earns NutraStrong certification, backed by clinical evidence on knee flexibility - Nutritional Outlook #Nutritional Outlook #UC-II Collagen
Lonza News Sep 12, 2025 Lonza CHI receives NutraStrong Collagen Verified certification - nutritioninsight.com #Collagen Verified #Lonza CHI
Lonza News Sep 10, 2025 SGS Nutrasource awards NutraStrong Collagen Verified certification to Lonza Capsules & Health Ingredients - Nutraceutical Business Review #Lonza Capsules #Health Ingredients
Lonza News Sep 8, 2025 ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands - PR Newswire #Files Patent #Patent Infringement
Lonza News Jul 23, 2025 A Swiss company bought Genentech's Vacaville plant — here's how it's going so far - San Francisco Business Times - The Business Journals #San Francisco #Genentech Vacaville
Lonza News Jul 2, 2025 Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge - BioSpectrum Asia #manufacturing readiness #Lonza leaders
Lonza News Apr 7, 2025 Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - GEN - Genetic Engineering and Biotechnology News #Genetic Engineering #Lonza Collaborate
Lonza News Mar 18, 2025 Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 - Contract Pharma #Contract Pharma #Therapeutics Chooses
Lonza News Mar 11, 2025 Exogenus Therapeutics Taps Lonza to Develop a GMP-Compliant Process for Lead Exosome-Based Candidate - GEN - Genetic Engineering and Biotechnology News #Genetic Engineering #Therapeutics Taps